In-situ Eutectic Formation during Reactive Melt Extrusion as a Mean to Improve Dissolution Performance for Benzimidazole Derivative Drugs

Research output: Contribution to conferencePosterpeer-review

Abstract

Benzimidazole is widely regarded as an important pharmacophore within the field of cancer research owing to its versatile scaffold that could be derivatised to provide a range of mechanisms of action against tumour progression. Facile synthetic strategies based on the bicyclic fused ring have led to potential and ongoing developments of target-specific and highly-effective anticancer agents. Such a promising central structure, however, inherits poor aqueous solubility from one of the parent reagents, benzene, limiting the derivatives’ therapeutic effectiveness and stalling their development progress. In the current study, we explored the potential of forming a eutectic complex between a benzimidazole derivative drug, albendazole (ABZ), and a highly soluble guest molecule, maleic acid (MA), as a solubility enhancement strategy. The said eutectic system was formed in-situ within polymeric formulation matrices during hot-melt extrusion (HME) processing.
Original languageEnglish
Publication statusPublished - 25 Jul 2021
Event2021 Controlled Release Society (CRS) Virtual Annual Meeting - Virtual
Duration: 25 Jul 202129 Jul 2021
https://2021.controlledreleasesociety.org/

Conference

Conference2021 Controlled Release Society (CRS) Virtual Annual Meeting
Period25/07/202129/07/2021
Internet address

Fingerprint

Dive into the research topics of 'In-situ Eutectic Formation during Reactive Melt Extrusion as a Mean to Improve Dissolution Performance for Benzimidazole Derivative Drugs'. Together they form a unique fingerprint.

Cite this